Courier Capital’s ImmunityBio IBRX Stock Holding History

Courier Capital’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.06M	Buy	112,000 +56,000	+100%	+$448K	0.2%	94
2026 Q2	$490K	Hold	56,000	–	–	0.02%	290
2026 Q1	$430K	Hold	56,000	–	–	0.02%	292
2025 Q4	$111K	Buy	56,000 +6,000	+12%	+$13.6K	0.01%	381
2025 Q3	$123K	Buy	50,000 +5,000	+11%	+$12.9K	0.01%	387
2025 Q2	$119K	Buy	45,000 +5,000	+13%	+$13.4K	0.01%	382
2025 Q1	$120K	Buy	40,000 +10,000	+33%	+$30.3K	0.01%	370
2024 Q4	$76.8K	Hold	30,000	–	–	0.01%	359
2024 Q3	$112K	Buy	30,000 +10,000	+50%	+$46.3K	0.01%	356
2024 Q2	$126K	Hold	20,000	–	–	0.01%	337
2024 Q1	$107K	Buy	20,000 +5,000	+33%	+$22.6K	0.01%	356
2023 Q4	$75.3K	Buy	+15,000	New	+$47.1K	0.01%	354

Other funds holding IBRX

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return

MWM

MFG Wealth Management Indianapolis, Indiana $138M AUM 31.54% 1-Year Est. Return

CFO

Collective Family Office York, Pennsylvania $484M AUM 13.93% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return

GWSA

Global Wealth Strategies & Associates Denver, Colorado $546M AUM 14.96% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

PCA

Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return

FWP

Firethorn Wealth Partners Augusta, Georgia $313M AUM 15.55% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Courier Capital's IBRX Position: Q3 2026 in Review

Courier Capital increased its ImmunityBio (IBRX) stake by 100% in Q3 2026, buying an estimated $448K and bringing the position to 112,000 shares worth $1.06M. The position accounts for 0.2% of the portfolio, ranked #94.

Courier Capital first reported a position in IBRX in Q4 2023 and has held it in 12 quarters since. 27 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

Courier Capital held 112,000 shares of ImmunityBio worth $1.06M as of Q3 2026.
Courier Capital bought 56,000 ImmunityBio shares in Q3 2026, an estimated $448K.
ImmunityBio made up 0.2% of Courier Capital's portfolio in Q3 2026, its #94 holding.
Courier Capital first reported a position in ImmunityBio in Q4 2023 and has held it in 12 quarters since.
27 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Courier Capital's 13F filing for Q3 2026, filed 13 Oct 2026.